[This Form 6-K consists of: 2. A circular regarding proposals relating to the change of directors, amendments to the articles of association, and the general mandate to issue new Shares to be proposed at the AGM; and 3. An announcement regarding update of certain connected transaction; Document 1]
[FORM 10-Q (Mark One) x March 31, 2015 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 11, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321033115.htm]
[Description 99.1 Announcement on 2015/05/11: To Announce the Issuance of Zero Coupon Convertible Bonds Due 2020 1 To Announce the Issuance of Zero Coupon Convertible Bonds Due 2020 1. Date of occurrence of the event: 2015/05/11 (1)Issue Size: US$600,000,000; Issue Price: 100% of principal amount; Denomination: US$200,000 (2)Coupon Rate: 0% per annum. (3)Redemption and expiration: Unless previously redeemed, converted or] [FORM 6-K May 11, 2015 United Microelectronics Corporation No. 3 Li Hsin Road II x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu CFO Description 99 6K on 05/11/2015 6-K 1 htm_9460.htm LIVE FILING]
[This Form 6-K consists of: 2. A circular regarding proposals relating to the change of directors, amendments to the articles of association, and the general mandate to issue new Shares to be proposed at the AGM; and 3. An announcement regarding update of certain connected transaction; Document 1]
[Mindray Announces First Quarter 2015 Financial Results SHENZHEN, China, May 11, 2015 -- Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the first quarter ended March 31, 2015. Highlights for First Quarter 2015 - Net revenues increased 2.9% year-over-year to $272.5 million. o] []
[ChipMOS TECHNOLOGIES (Bermuda) LTD. By S. J. Cheng Chairman & Chief Executive Officer Contacts: In Taiwan In the U.S. Dr. S.K. Chen David Pasquale ChipMOS TECHNOLOGIES (Bermuda) LTD. Global IR Partners +886-6-507-7712 +1-914-337-8801 s.k._chen@chipmos.com]
[May 11 , 2015 Ms. Sharon Blume Mr. Mark Brunhofer Mr. Jim B. Rosenberg Division of Corporation Finance 100F Street, NE Mail Stop 7010 U.S.A. Re: iKang Healthcare Group, Inc. Form 20-F for the Fiscal Year Ended March 31, 2014 Filed July 25, 2014 and Amended July 31, 2014 File No. 1-36403 Dear Ms. Sharon Blume, Mr. Mark Brunhofer and]
[Mindray Announces First Quarter 2015 Financial Results SHENZHEN, China, May 11, 2015 -- Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the first quarter ended March 31, 2015. Highlights for First Quarter 2015 - Net revenues increased 2.9% year-over-year to $272.5 million. o] []
[Gulf Resources Announced the Assessment Results of Natural Gas Resources Under Its Bromine Well in Sichuan SHOUGUANG, China, May 7, 2015 (GLOBE NEWSWIRE) -- Gulf Resources, Inc. (Nasdaq:GURE) ("Gulf Resources" or the "Company" or "GURE"), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced the assessment results of natural gas resources under its bromine] [+86 (536) 567-0008 o o o o Item 8.01. Other Events. On May 7, 2015, Gulf Resources, Inc. (“Gulf Resources” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in China, announced the assessment results of natural gas resources under its bromine well in Sichuan. According to the report, the major results of the study]
[ChipMOS TECHNOLOGIES (Bermuda) LTD. By S. J. Cheng Chairman & Chief Executive Officer Contacts: In Taiwan In the U.S. Dr. S.K. Chen David Pasquale ChipMOS TECHNOLOGIES (Bermuda) LTD. Global IR Partners +886-6-507-7712 +1-914-337-8801 s.k._chen@chipmos.com]
